Gland Pharma Ltd Annually Results

Gross Sales

5,616.5

5,664.72

3,624.6

4,400.71

3,462.88

Excise Duty

0

0

0

0

0

Net Sales

5,616.5

5,664.72

3,624.6

4,400.71

3,462.88

Other Operating Income

0

0

0

0

0

Other Income

213.61

170.24

240.46

223.94

134.78

Total Income

5,830.11

5,834.96

3,865.06

4,624.65

3,597.65

Total Expenditure

4,347.58

4,331.65

2,656.3

2,890.56

2,160.65

PBIDT

1,482.53

1,503.31

1,208.77

1,734.09

1,437

Interest

42

26.2

7.45

5.24

3.41

PBDT

1,440.53

1,477.11

1,201.32

1,728.85

1,433.59

Depreciation

377.87

344.57

146.74

110.3

98.78

Minority Interest Before NP

0

0

0

0

0

Tax

371.97

345.75

276.34

392.88

337.73

Deferred Tax

-7.84

14.33

-2.8

14.01

0.12

Reported Profit After Tax

698.53

772.46

781.04

1,211.66

996.96

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

698.53

772.46

781.04

1,211.66

996.96

Extra-ordinary Items

0

0

-41.67

0

0

Adjusted Profit After Extra-ordinary item

698.53

772.46

822.71

1,211.66

996.96

EPS (Unit Curr.)

42.4

46.9

47.44

73.81

63.07

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,800

2,000

0

0

0

Equity

16.48

16.47

16.47

16.43

16.36

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.39

26.53

33.34

39.4

41.49

PBDTM(%)

25.64

26.07

33.14

39.28

41.39

PATM(%)

12.43

13.63

21.54

27.53

28.78